PTPN13 and malignant colon neoplasm: In line with these observations, inhibition of the PTPN13FAS interaction with the SLV peptide in PTPN13-overexpressing CD133-positive colon cancer stem cells increases their responsiveness to oxaliplatin, restoring FAS-induced apoptosis [34].